• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C.

作者信息

Adinolfi Luigi Elio, Rinaldi Luca, Marrone Aldo, Giordano Mauro

机构信息

a Department of Medical, Surgical, Neurological, Metabolic, and Geriatric Sciences , University of Campania 'L. Vanvitelli , Naples , Italy.

出版信息

Expert Rev Anti Infect Ther. 2018 Aug;16(8):595-597. doi: 10.1080/14787210.2018.1505500. Epub 2018 Aug 1.

DOI:10.1080/14787210.2018.1505500
PMID:30047799
Abstract
摘要

相似文献

1
The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C.直接抗病毒药物实现的持续病毒学应答对慢性丙型肝炎患者胰岛素抵抗和糖尿病的影响。
Expert Rev Anti Infect Ther. 2018 Aug;16(8):595-597. doi: 10.1080/14787210.2018.1505500. Epub 2018 Aug 1.
2
Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance.直接作用抗病毒药物清除丙型肝炎病毒可改善胰岛素抵抗。
J Viral Hepat. 2020 Feb;27(2):188-194. doi: 10.1111/jvh.13215. Epub 2019 Dec 2.
3
[A new challenge in clinical practice: resistance to directly acting antivirals in hepatitis C treatment].[临床实践中的一项新挑战：丙型肝炎治疗中对直接作用抗病毒药物的耐药性]
Zhonghua Gan Zang Bing Za Zhi. 2016 Mar 20;24(3):165-9. doi: 10.3760/cma.j.issn.1007-3418.2016.03.002.
4
Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype.由于病毒基因型的转变，口服直接抗病毒药物治疗未能治愈一名慢性丙型肝炎患者。
J Gastrointestin Liver Dis. 2017 Jun;26(2):205-206. doi: 10.15403/jgld.2014.1121.261.yeh.
5
Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.直接作用抗病毒药物治疗慢性丙型肝炎获得持续病毒学应答后骨骼肌质量增加的相关预测因素。
Nutrients. 2017 Oct 18;9(10):1135. doi: 10.3390/nu9101135.
6
Direct antiviral treatment of chronic hepatitis C in heart transplant recipients.心脏移植受者慢性丙型肝炎的直接抗病毒治疗。
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12813. Epub 2017 Dec 21.
7
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.直接作用抗病毒药物和宿主靶向药物时代的慢性丙型肝炎病毒感染的治疗。
J Infect. 2014 Jan;68(1):1-20. doi: 10.1016/j.jinf.2013.08.019. Epub 2013 Sep 4.
8
Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study).直接作用抗病毒疗法对埃及慢性丙型肝炎患者胰岛素抵抗和2型糖尿病的影响（前瞻性研究）
Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2641-2646. doi: 10.1016/j.dsx.2019.07.032. Epub 2019 Jul 13.
9
The remaining challenges of HCV treatment in the direct-acting antivirals era.直接作用抗病毒药物时代丙型肝炎病毒治疗的剩余挑战。
J Gastroenterol Hepatol. 2019 Nov;34(11):1891-1892. doi: 10.1111/jgh.14916.
10
Hepatitis C Virus and Antiviral Drug Resistance.丙型肝炎病毒与抗病毒药物耐药性
Gut Liver. 2016 Nov 15;10(6):890-895. doi: 10.5009/gnl15573.

引用本文的文献

1
Metabolic aspects of hepatitis C virus.丙型肝炎病毒的代谢方面。
World J Gastroenterol. 2022 Jun 14;28(22):2429-2436. doi: 10.3748/wjg.v28.i22.2429.
2
Glycemic Control in Patients Undergoing Treatment With Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir for Chronic Hepatitis C Infection.接受帕利瑞韦/奥比他韦/利托那韦和达萨布韦治疗的慢性丙型肝炎感染患者的血糖控制。
In Vivo. 2022 May-Jun;36(3):1438-1443. doi: 10.21873/invivo.12849.
3
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review.代谢综合征中非酒精性脂肪性肝病的机制。一篇叙述性综述。
Antioxidants (Basel). 2021 Feb 10;10(2):270. doi: 10.3390/antiox10020270.
4
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.基于直接作用抗病毒药物的方案对丙型肝炎病毒相关肝外损伤的影响：一项叙述性综述。
Adv Exp Med Biol. 2021;1323:115-147. doi: 10.1007/5584_2020_604.
5
NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.非酒精性脂肪性肝炎、代谢综合征与糖尿病：糖和脂肪如何增加发展为晚期肝病的风险。
Dig Dis Sci. 2021 Jul;66(7):2147-2148. doi: 10.1007/s10620-020-06620-9. Epub 2020 Sep 26.
6
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes.持续的丙型肝炎治疗病毒学应答可降低与 2 型糖尿病相关并发症的发生率。
Aliment Pharmacol Ther. 2019 Mar;49(5):599-608. doi: 10.1111/apt.15102. Epub 2019 Jan 16.
7
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?慢性丙型肝炎、动脉粥样硬化和心血管疾病：直接作用抗病毒治疗有何影响？
World J Gastroenterol. 2018 Nov 7;24(41):4617-4621. doi: 10.3748/wjg.v24.i41.4617.